Rhino Biotech Limited
RBRXF
Other OTC0.00
USD
+0.00
- -
Rhino Biotech Limited
RBRXF
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Rhino Biotech Limited (OTC:RBRXF) develops plant- and fungi-derived nutraceuticals and biopharmaceuticals for preventative and curative applications in health and wellness. The company operates through three primary divisions: Fortify RX, which produces, manufactures, and distributes cannabis-derived cannabinoids and natural compounds for nutraceuticals, pharmaceuticals, and health products; AGRITECH RHINO (formerly Artesian Valley Agritech), which improves plant and fungus genetics via cloning and hybridization technologies, including proprietary Cannabis Sativa L. strains such as "Chiron" yielding up to 18.1% CBG with minimal THC; and BioOrganics, which conducts research and development focused on preventing contamination, deterioration, and extending the lifespan and efficacy of organic compounds sourced from plants, fungi, and microorganisms. These offerings target nutraceutical, biopharmaceutical, and agritech markets, with products including cannabinoid isolates, proprietary formulations for health fortification, and genetics for medical research. In recent developments, Rhino Biotech acquired Colorado-based Artesian Valley Farms, LLC (dba Artesian Valley Agritech) for $14.5 million in shares and $3.4 million in financing, along with Nevada-based JRD Ventures, LLC for $3.1 million in shares to secure related intellectual property, and Ohio-based Rhino Biotech, Inc. for $10 million in shares, totaling approximately $22.5 million in transactions completed in 2021 and 2022 to vertically integrate its biotech operations. The company, formerly known as Eurasia Energy Limited, underwent a name change in September 2021 and appointed a new interim board of directors in February 2022 to drive rapid growth. Recent notices issued in February 2025 indicate ongoing shareholder communications amid strategic initiatives. Founded in 2003 and headquartered at 294 Heywood House, South Hill, Anguilla, Rhino Biotech employs a small team of three and maintains mailing operations in Longmont, Colorado, with a focus on global agritech, biotech, and biopharma segments.